{"id":967776,"date":"2026-05-27T16:34:22","date_gmt":"2026-05-27T20:34:22","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york\/"},"modified":"2026-05-27T16:34:22","modified_gmt":"2026-05-27T20:34:22","slug":"imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york\/","title":{"rendered":"ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York"},"content":{"rendered":"
\n

SAN DIEGO, May 27, 2026 (GLOBE NEWSWIRE) — ImageneBio, Inc. (Nasdaq: IMA) (\u201cImagene\u201d or the \u201cCompany\u201d) today announced that chief executive officer Kristin Yarema, Ph.D., will present at the Jefferies Global Healthcare Conference in New York on June 4, 2026 and management will participate in one-on-one meetings.<\/p>\n

\n Jefferies Global Healthcare Conference in New York<\/strong>
\n
Date: Thursday, June 4, 2026
Time: 12:50 PM EDT
Webcast: Linked\u00a0here<\/a>\u00a0and archived for 90 days on events page on the Imagene IR website<\/p>\n

\n About ImageneBio, Inc. <\/strong>
\n
\n Imagene<\/a> is a clinical-stage biotechnology company dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases with differentiated clinical profiles. The Company’s program, IMG-007, is a receptor targeting, non-T cell-depleting, ADCC-silenced, anti-OX40 monoclonal antibody with an approximately 5-week half-life. Imagene is currently conducting a Phase 2b clinical trial of IMG-007 in patients with moderate-to-severe atopic dermatitis. The Company has also completed a proof-of-concept trial and plans to initiate a Phase 2 study in alopecia areata.<\/p>\n

\n Company and Investor Contact<\/strong>
\n
Rebecca Cohen
rcohen@imagenebio.com<\/a><\/p>\n

\n Media Contact<\/strong>
\n
Jason Braco, PhD
The Health & Science Agency
jason@healthscienceagency.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN DIEGO, May 27, 2026 (GLOBE NEWSWIRE) — ImageneBio, Inc. (Nasdaq: IMA) (\u201cImagene\u201d or the \u201cCompany\u201d) today announced that chief executive officer Kristin Yarema, Ph.D., will present at the Jefferies Global Healthcare Conference in New York on June 4, 2026 and management will participate in one-on-one meetings. Jefferies Global Healthcare Conference in New York Date: Thursday, June 4, 2026Time: 12:50 PM EDTWebcast: Linked\u00a0here\u00a0and archived for 90 days on events page on the Imagene IR website About ImageneBio, Inc. Imagene is a clinical-stage biotechnology company dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases with differentiated clinical profiles. The Company’s program, IMG-007, is a receptor targeting, non-T cell-depleting, ADCC-silenced, anti-OX40 monoclonal antibody with an approximately 5-week half-life. Imagene … <\/p>\n

Continue reading “ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-967776","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, May 27, 2026 (GLOBE NEWSWIRE) — ImageneBio, Inc. (Nasdaq: IMA) (\u201cImagene\u201d or the \u201cCompany\u201d) today announced that chief executive officer Kristin Yarema, Ph.D., will present at the Jefferies Global Healthcare Conference in New York on June 4, 2026 and management will participate in one-on-one meetings. Jefferies Global Healthcare Conference in New York Date: Thursday, June 4, 2026Time: 12:50 PM EDTWebcast: Linked\u00a0here\u00a0and archived for 90 days on events page on the Imagene IR website About ImageneBio, Inc. Imagene is a clinical-stage biotechnology company dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases with differentiated clinical profiles. The Company’s program, IMG-007, is a receptor targeting, non-T cell-depleting, ADCC-silenced, anti-OX40 monoclonal antibody with an approximately 5-week half-life. Imagene … Continue reading "ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-27T20:34:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNzU2NSM3NjI0MDEyIzIyMDU4NzY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York\",\"datePublished\":\"2026-05-27T20:34:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york\\\/\"},\"wordCount\":182,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNzU2NSM3NjI0MDEyIzIyMDU4NzY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york\\\/\",\"name\":\"ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNzU2NSM3NjI0MDEyIzIyMDU4NzY=\",\"datePublished\":\"2026-05-27T20:34:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNzU2NSM3NjI0MDEyIzIyMDU4NzY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNzU2NSM3NjI0MDEyIzIyMDU4NzY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york\/","og_locale":"en_US","og_type":"article","og_title":"ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York - Market Newsdesk","og_description":"SAN DIEGO, May 27, 2026 (GLOBE NEWSWIRE) — ImageneBio, Inc. (Nasdaq: IMA) (\u201cImagene\u201d or the \u201cCompany\u201d) today announced that chief executive officer Kristin Yarema, Ph.D., will present at the Jefferies Global Healthcare Conference in New York on June 4, 2026 and management will participate in one-on-one meetings. Jefferies Global Healthcare Conference in New York Date: Thursday, June 4, 2026Time: 12:50 PM EDTWebcast: Linked\u00a0here\u00a0and archived for 90 days on events page on the Imagene IR website About ImageneBio, Inc. Imagene is a clinical-stage biotechnology company dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases with differentiated clinical profiles. The Company’s program, IMG-007, is a receptor targeting, non-T cell-depleting, ADCC-silenced, anti-OX40 monoclonal antibody with an approximately 5-week half-life. Imagene … Continue reading \"ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-27T20:34:22+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNzU2NSM3NjI0MDEyIzIyMDU4NzY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York","datePublished":"2026-05-27T20:34:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york\/"},"wordCount":182,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNzU2NSM3NjI0MDEyIzIyMDU4NzY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york\/","name":"ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNzU2NSM3NjI0MDEyIzIyMDU4NzY=","datePublished":"2026-05-27T20:34:22+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNzU2NSM3NjI0MDEyIzIyMDU4NzY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNzU2NSM3NjI0MDEyIzIyMDU4NzY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/967776","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=967776"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/967776\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=967776"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=967776"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=967776"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}